JAMP ATAZANAVIR
Identification of Jamp Atazanavir
| No description |
Google image searchProduct monograph
Active ingredient
atazanavir (atazanavir sulfate), 300 MG
DIN: 02513129
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 31-JAN-2023
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AE — Protease inhibitors (ATC, ATC/DDD)
- J05AE08 — ATAZANAVIR (ATC/DDD)
Reference brand drug: Reyataz
Pharmaceutical standard: MFR
